NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216 | -100.0% | 2,124 | -92.6% | 0.03% | -86.1% |
| Q2 2021 | $2,624,000 | -40.8% | 28,768 | -38.5% | 0.24% | +76.9% |
| Q4 2019 | $4,429,000 | -30.6% | 46,778 | -36.3% | 0.13% | -60.7% |
| Q3 2019 | $6,379,000 | +71.0% | 73,412 | +48.6% | 0.34% | +342.9% |
| Q2 2018 | $3,731,000 | +203.1% | 49,400 | +216.7% | 0.08% | +87.8% |
| Q3 2016 | $1,231,000 | +145.2% | 15,600 | +205.9% | 0.04% | -14.6% |
| Q1 2015 | $502,000 | -26.7% | 5,100 | -31.1% | 0.05% | -54.7% |
| Q4 2014 | $685,000 | +19.3% | 7,400 | +21.3% | 0.11% | -4.5% |
| Q3 2014 | $574,000 | -44.2% | 6,100 | -49.6% | 0.11% | +126.5% |
| Q1 2014 | $1,028,000 | +14.2% | 12,100 | +8.0% | 0.05% | -43.7% |
| Q4 2013 | $900,000 | +86.3% | 11,200 | +77.8% | 0.09% | +102.3% |
| Q3 2013 | $483,000 | – | 6,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |